Cost of illness of Alzheimer's disease: How useful are current estimates?

Gerontologist

Volumn 43, Issue 2, 2003, Pages 158-164

  Bloom, Bernard S ^a   De Pouvourville, Nathalie ^b   Straus, Walter L ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Alzheimer's disease; Cost; Dementia; Economics

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COST OF ILLNESS; DEMENTIA; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; PREVALENCE; PURCHASING; UNITED STATES;

EID: 0037387097     PISSN: 00169013     EISSN: None     Source Type: Journal    
DOI: 10.1093/geront/43.2.158     Document Type: Article

References (42)

1. Bloom, B. S., Bruno, D. J., Maman, D., & Jayadevappa, R. (2001). Usefulness of cost of illness studies in health care decision making. Pharmaco-Economics, 19, 207-213.
2. Brookmeyer, R., Gray, S., & Kawas, C. (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health, 88, 1337-1342.
3. Cavallo, M. C., & Fattore, G. (1997). The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Disease and Associated Disorders, 11, 184-190.
4. Coon, D. W., & Edgerly, E. S. (1999). The personal and social consequences of Alzheimer's disease. Genetic Testing, 3, 29-36.
5. Drummond, M. F., O'Brien, B., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health hare programs (2nd ed.). Oxford, England: Oxford University Press.
6. Ernst, R. L., & Hay, J. W. (1994). The US economic and social costs of Alzheimer's disease revisited. American Journal of Public Health, 84, 1261-1264.
7. Ernst, R. L., & Hay, J. W. (1997). Economic research on Alzheimer disease: A review of the literature. Alzheimer Disease & Associated Disorders, 11(Suppl. 6), 135-145.
8. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. Oxford, England: Oxford University Press.
9. Gray, A., & Fenn, P. (1993). Alzheimer's disease: The burden of illness in England. Health Trends, 25, 31-37.
10. Gutterman, E. M., Markowitcz, J. S., Lewis, B., & Fillit, H. (1999). Cost of Alzheimer's disease and related dementia in managed-Medicare. Journal of the American Geriatrics Society, 47, 1065-1071
11. Huang, L.-F., Cartwright, W. S., & Teh-Wei, H. (1998). The economic cost of senile dementia in the United States. Public Health Reports, 103, 3-7.
12. Hux, M. J., O'Brien, B. J., Iskedjian, M., Goeree, R., Gagnon, M., & Gauthier, S. (1998). Relation between severity of Alzheimer's disease and costs of caring. Canadian Medical Association Journal, 159, 457-465.
13. Jefferson, T., Demicheli, V., & Mugford, M. (2000). Elementary economic evaluation in health care (2nd ed.). London: BMJ Books.
14. Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987). The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatrica Scandinavica, 76, 465-479.
15. Kavanagh, S. K., & Knapp, M. (1999). Cognitive disability and direct care costs for elderly people. British Journal of Psychiatry, 174, 539-546.
16. Kinosian, B. P., Stallard, E., Lee, J. H., Woodbury, M. A., Zbrozek, A. S., & Glick, H. A. (2000). Predicting 10-year care requirements for older people with suspected Alzheimer's disease. Journal American Geriatrics Society, 48, 631-638.
17. Kronborg-Andersen, C., Søgaard, J., Hansen, E., Kragh-Sorensen, A., Hastrup, L., Andersen, J., et al. (1999). The cost of dementia in Denmark: The Odense study. Dementia and Geriatric Cognitive Disorders, 10, 295-304.
18. Lee, D. W., Meyer, J. W., & Clouse, J. (2001). Implications of controlling for comorbid conditions in cost-of-illness estimates: A case study of osteoarthritis from a managed care perspective. Value in Health, 4, 329-334.
19. Leon, J., Cheng, C.-K., & Neumann, P. J. (1998). Alzheimer's disease care: Costs and potential savings. Health Affairs, 17, 206-216.
20. Lobo, A., Launer, L. J., Fratiglioni, L., Andersen, K., Di Carlo, A., Breteler, M. M., et al. (2000). Prevalence of dementia and major subtypes in Europe: A collaborative study of population-base cohorts. Neurology, 54(Suppl. 5), S4-S9.
21. Max, W., Webber, P., & Fox, P. (1995). Alzheimer's disease: The unpaid burden of caring. Journal of Aging and Health, 7, 179-199.
22. McDonnell, J., Redekop, W. K., van der Roer, N., Goes, E., Ruitenberg, A., Bussbach, J. J. V., et al. (2001). The cost of treatment of Alzheimer's disease in the Netherlands. PharmacoEconomics, 19, 379-390.
23. Meek, P. D., McKeithan, K., & Schumock, G. T. (1998). Economic considerations in Alzheimer's disease. Pharmacotherapy, 18(Pt. 2), 68-73.
24. Menzin, J., Lang, K., Friedman, M., Neumann, P., & Cummings, J. L. (1999). The economic cost of Alzheimer's disease and related dementias to the California Medicaid Program ("Medi-Cal") in 1995. American Journal of Geriatric Psychiatry, 7, 300-308.
25. Newcomer, R., Clay, R., Luxenberg, K. S., & Miller, R. H. (1999). Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. Journal American Geriatrics Society, 47, 215-219.
26. O'Brien, B. J., Goeree, R., Hux, M., Iskedjian, M., Blackhouse, G., Gagnon, M., et al. (1999). Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada. Journal of the American Geriatrics Society, 47, 570-578.
27. O'Shea, E., & O'Reilly, S. (2000). The economic and social cost of dementia in Ireland. International Journal of Geriatric Psychiatry, 15, 208-218.
28. Østbye, T., & Crosse, E. (1994). Net economic costs of dementia in Canada. Canadian Medical Association Journal, 151, 1457-1464.
29. Pagano, E., Brunetti, M., Tediosi, F., & Garattini, L. (1997). Costs of diabetes: A methodological analysis of the literature. PharmacoEconomics, 15, 583-595.
30. Rice, D. P., Fox, P. J., Max, W., Webber, P. A., Lindeman, D. A., Hauck, W. W., et al. (1993). The economic burden of Alzheimer's disease care. Health Affairs Summer, 11, 164-176.
31. Ritchie, K., Kildea, D., & Robine, J. M. (1992). The relationship between age and the prevalence of senile dementia: A meta analysis of recent data. International Journal of Epidemiology, 21, 763-769.
32. Schneider, J., Kavanaugh, S., Knapp, M., Beecham, J., & Netten, A. (1993). Elderly people with advanced cognitive impairment in England. Resource use and costs. Aging Society, 13, 27-50.
33. Schumock, G. T. (1998). Economic considerations in the treatment and management of Alzheimer's disease. American Journal of Health System Pharmacy, 55(Suppl. 20), S17-S21.
34. Souêtre, E., Thwaites, R. M., & Yeardley, H. M. (1999). Economic impact of Alzheimer's disease in the UK. Cost of care and disease severity for non-institutionalized patients with Alzheimer's disease. British Journal of Psychiatry, 174, 51-55.
35. Taylor, D. H., & Sloan, F. A. (2000). How much do persons with Alzheimer's disease cost Medicare? Journal American Geriatrics Society, 48, 639-646.
36. Trabucchi, M. (1999). An economic perspective on Alzheimer's disease. Journal of Geriatric Psychiatry & Neurology, 12, 29-38.
37. U.S. Bureau of the Census. (1999). Statistical abstract of the United States: 1999 (119th ed.). Washington, DC: U.S. Government Printing Office.
38. Weinberger, M., Gold, D. T., Divine, G. W., Cowper, P. A., Hodgson, L. G., Schreiner, M. S., et al. (1993). Expenditures in caring for patients with dementia who live at home. American Journal of Public Health, 83, 338-341.
39. Weiner, M., Powe, N. R., Weller, W. E., Shaffer, T. J., & Anderson, G. F. (1998). Alzheimer's disease under managed care: Implications from Medicare utilization and expenditure patterns. Journal American Geriatrics Society, 46, 762-770.
40. Wimo, A., Karlsson, G., Sandman, P. O., Corder, L., & Winblad, B. (1998). Cost of illness due to dementias in Sweden. International Journal of Geriatric Psychiatry, 12, 857-861.
41. Winblad, B., & Wimo, A. (1999). Assessing the societal impact of acetyl-cholinesterase inhibitor therapies. Alzheimer Disease and Associated Disorders, 13(Suppl. 2), S9-S19.
42. World Bank Group. (2000). The 2000 world development indicators (Version 4.2) [CD-ROM *Stars]. Washington, DC: International Bank for Reconstruction and Development.